BRKR · NASDAQ · STOCK
Bruker (BRKR) Stock Analysis
$58.48
52W $29.84 – $65.30
67/100
$9.04B
-85.0
1.27
Is BRKR Bullish or Bearish?
Bullish.
Innellis AI committee rates Bruker (BRKR) Buy with a composite score of 67/100
, based on 4 analysts with 75% agreement.
Last updated September 05, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +7.81 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -12.19 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 05, 2026
Overall Committee Score
67/100
Agreement
75%
Analysts
4
Conviction
High
Sector Rank
Top 6%
of 192 Healthcare peers
Growth Analyst
bullish
85
/ 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− Price structure (LH_LL) contradicts the uptrend -- mixed signals
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3059.07)
Investment Thesis Evolution
Committee score strengthened from 57.8 to 67.2.
- Recommendation changed from Watch to Buy.
- Conviction changed from moderate to high.
- Committee agreement increased notably from 60% to 75%.
- Bearish pressure eased: 1 signal(s) disappeared.
- Analyst(s) abstained: Value Analyst.
Analyst-level changes:
- Growth Analyst: score 62->85 (+22).
- Value Analyst abstained (was neutral at 42).
Comparing 2026-09-04 to 2026-09-05 (1 day apart).
Technical Analysis
RSI (14)
57.0
Neutral
MACD Histogram
0.138
Bullish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Lh Ll
Support
$56.08
Resistance
$64.46
Bollinger %B
0.78
Inside Bands
Price vs Moving Averages
EMA 9
$58.12
Above
EMA 21
$58.01
Above
EMA 50
$57.11
Above
EMA 200
$49.84
Above
Fundamental Analysis
Valuation
88
Growth
81
Profitability
17
Financial Health
86
Cash Flow
70
Valuation
P/E Ratio
-85.0×
P/B Ratio
3.77×
PEG Ratio
0.97
Dividend Yield
0.34%
52W High
$65.30
52W Low
$29.84
Quality & Growth
ROE
-35.0%
ROA
-13.8%
Gross Margin
4668.8%
Operating Margin
361.5%
Revenue Growth YoY
—
Debt / Equity
0.80
AI Fundamental Assessment
P/E ratio of -85.0 (inexpensive relative to a 15-40x range); Price-to-book of 3.8x; PEG ratio of 1.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -0.4%; Return on assets of -0.1%; Net margin of -2.0%; Gross margin of 46.7%; Current ratio of 1.85 (healthy short-term liquidity); Debt-to-equity of 0.80; Free cash flow per share is positive (0.62); Most recent quarter beat estimates by 24.9%; 2 consecutive earnings beats; EPS growth accelerating (-47.5% -> +58.1% QoQ); Average YoY EPS growth of 53.1%; Analyst estimates falling over recent quarters
Get the Full BRKR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →